HK1108924A1 - Cancer prognostic methods - Google Patents

Cancer prognostic methods

Info

Publication number
HK1108924A1
HK1108924A1 HK08103011.1A HK08103011A HK1108924A1 HK 1108924 A1 HK1108924 A1 HK 1108924A1 HK 08103011 A HK08103011 A HK 08103011A HK 1108924 A1 HK1108924 A1 HK 1108924A1
Authority
HK
Hong Kong
Prior art keywords
prognostic methods
cancer prognostic
cancer
methods
prognostic
Prior art date
Application number
HK08103011.1A
Other languages
English (en)
Inventor
Adrian M Jubb
Hartmut Koeppen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of HK1108924A1 publication Critical patent/HK1108924A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK08103011.1A 2005-01-06 2008-03-14 Cancer prognostic methods HK1108924A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64216405P 2005-01-06 2005-01-06
PCT/US2006/000497 WO2006074392A2 (en) 2005-01-06 2006-01-05 Cancer prognostic, diagnostic and treatment methods

Publications (1)

Publication Number Publication Date
HK1108924A1 true HK1108924A1 (en) 2008-05-23

Family

ID=36648221

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08103011.1A HK1108924A1 (en) 2005-01-06 2008-03-14 Cancer prognostic methods

Country Status (9)

Country Link
US (2) US20080008705A1 (xx)
EP (1) EP1833996B1 (xx)
JP (2) JP5007238B2 (xx)
AU (1) AU2006203884B2 (xx)
CA (1) CA2593325A1 (xx)
ES (1) ES2398568T3 (xx)
HK (1) HK1108924A1 (xx)
NZ (1) NZ556284A (xx)
WO (1) WO2006074392A2 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006210837B2 (en) * 2005-01-31 2012-07-12 Genentech, Inc. Anti-EphB2 antibodies and methods using same
NZ562237A (en) * 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
JP5130465B2 (ja) * 2007-12-25 2013-01-30 財団法人ヒューマンサイエンス振興財団 肝細胞癌マーカー及び肝細胞癌の検査方法
WO2010031749A1 (en) 2008-09-17 2010-03-25 Innate Pharma Compositions and methods for detecting tlr3
CA2914189C (en) * 2013-06-21 2023-03-14 Innate Pharma Enzymatic conjugation of polypeptides
CA3186062A1 (en) 2020-08-10 2022-02-17 Marion BENEZECH Cell surface mica and micb detection using antibodies
WO2022214432A1 (en) 2021-04-05 2022-10-13 Innate Pharma Immunohistochemistry methods and kir3dl2-specific reagents
CN113834941B (zh) * 2021-11-02 2024-01-05 复旦大学附属中山医院 基于b细胞表达的结肠癌预后诊断用标记物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100607612B1 (ko) 2001-06-20 2006-08-02 제넨테크, 인크. 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
US20050031627A1 (en) * 2002-01-03 2005-02-10 Mazzola Gregory J Methods for preparing immunoconjugates
DE03768629T1 (de) * 2002-11-05 2006-01-26 The Regents Of The University Of California, Oakland Verfahren und materialien zur untersuchung von mit glioblastomprogression assoziierten wegen
EP1583821A4 (en) * 2003-01-15 2007-07-18 Millennium Pharm Inc METHODS AND COMPOSITIONS FOR TREATING UROLOGICAL DISORDERS USING GENES 44390, 54181, 211, 5687, 884, 1405, 636, 4421, 5410, 30905, 2045, 16405, 18560, 2047, 33751, 52872, 14063, 20739, 32544, 43239, 44373, 51164, 53010, 16852, 1587, 2207, 22245, 2387, 52908, 69112, 14990, 18547, 115, 579
JP4762889B2 (ja) * 2003-03-12 2011-08-31 バスジーン セラピューティクス，インコーポレイテッド 血管形成及び腫瘍成長を阻止するための核酸化合物
US20080153104A1 (en) * 2003-08-08 2008-06-26 Hiroyuki Aburantai Gene Overexpressed in Cancer
US7402389B2 (en) * 2004-02-24 2008-07-22 The Translational Genomics Research Institute (Tgen) Compositions and methods for prognosis of cancers
AU2006210837B2 (en) * 2005-01-31 2012-07-12 Genentech, Inc. Anti-EphB2 antibodies and methods using same

Also Published As

Publication number Publication date
NZ556284A (en) 2009-11-27
AU2006203884A1 (en) 2006-07-13
JP2008527352A (ja) 2008-07-24
WO2006074392A3 (en) 2006-12-14
CA2593325A1 (en) 2006-07-13
US20080008705A1 (en) 2008-01-10
AU2006203884B2 (en) 2012-02-16
JP2012177698A (ja) 2012-09-13
EP1833996B1 (en) 2012-12-05
WO2006074392A2 (en) 2006-07-13
JP5007238B2 (ja) 2012-08-22
ES2398568T3 (es) 2013-03-20
US20090324595A1 (en) 2009-12-31
EP1833996A2 (en) 2007-09-19

Similar Documents

Publication Publication Date Title
GB0719792D0 (en) Cancer biomarkers
EP1934603A4 (en) BIOMARKER FOR PROSTATE CANCER
IL183501A0 (en) Lung cancer prognostics
EP1778856A4 (en) BLOOD BIOMARKER FOR CANCER
EP1872421A4 (en) MEANS FOR CONNECTING TERMINALS
EP1934823A4 (en) DETERMINATION OF A CLICK DISTANCE
EP1910821A4 (en) BIOMARKER FOR OVARIAL CARCINOMA
EP2061899A4 (en) BIOMARKERS FOR PROSTATE CANCER AND METHOD FOR THEIR USE
EP1859402A4 (en) ADVANCED METHODS AND SYSTEMS FOR ENSURING THE INTEGRITY OF A REGULATION
EP1943071A4 (en) DEVICE FOR FORMING EMPTY
EP1802764A4 (en) BIOLOGICAL MARKERS FOR BREAST CANCER
EP1907857A4 (en) BIOMARKERS OF BREAST CANCER
HK1108924A1 (en) Cancer prognostic methods
GB0525957D0 (en) Methods
GB0511302D0 (en) Biomarkers
ZA200801986B (en) Standard
EP1833631A4 (en) AVERAGE POSITIONING
GB0518232D0 (en) New methods
GB0715741D0 (en) Methods
GB0720953D0 (en) Slide
ZA200801877B (en) Narrow bench mining system
GB0518425D0 (en) Methods
GB0516204D0 (en) Methods
GB0526212D0 (en) Methods
GB0514661D0 (en) Methods

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180105